Dr Chetana Chandrashekar

Associate Professor

Department of Oral and Maxillofacial Pathology and Oral Microbiology

Department of Oral & Maxillofacial Pathology and Oral Microbiology

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    · Prepares course materials, syllabus and question papers for undergraduate program

    · Involved in practical classes & demonstrations of Dental Anatomy, Oral Histology & Oral Pathology

    · Guides PG students for their thesis work

    · Conducts formative and summative assessments for students

    · Provides histopathological diagnosis for oral lesions?

SUBJECTS CURRENTLY TEACHING

Subject Semester / Year
Dental Anatomy, Embryology and Oral Histology First year BDS
Oral Pathology and Microbiology Second year BDS
Oral Pathology and Microbiology Third year BDS
Oral and Maxillofacial Pathology and Oral Microbiology MDS

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
MDS Oral Pathology and Microbiology SDM College of Dental Sciences, Dharwad 2007
BDS SDM College of Dental Sciences, Dharwad 2000

Experience

Institution / Organisation Designation Role Tenure
Department of Oral Pathology, MCODS 必威体育betway888 Associate Professor October 2012- till date
Department of Oral Pathology, MCODS 必威体育betway888 Assistant Professor October 2007-October 2012

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Potentially malignant lesions and oral squamous cell carcinoma

Area of Expertise

Potentially malignant lesions and oral squamous cell carcinoma

Professional Affiliations & Contributions

  • Member of the 必威体育betway888 Association of Oral Pathologists
  • Life Member of Indian Association of Oral and Maxillofacial Pathologist
  • Member of Indian Dental Association

Verma V, Chandrashekar C. Evaluation of SOX2 and podoplanin expression in oral epithelial dysplasia and its correlation with malignant transformation.?J Investig Clin Dent. 2019;10(4):e12450.

Sah P, Patel P, Chandrashekar C, Martena S, Ballal M, Hegde M, Guddattu V, Murdoch C, Sharma M, Radhakrishnan R. Oral candidal carriage correlates with CD4+?cell count but not with HIV and highly active antiretroviral therapy status.?J Investig Clin Dent. 2019;10(4):e12438.

Bhat A, Mitra S, Chandrashekar C, Solomon M, Kulkarni S. Odontogenic cysts?and?odontogenic?tumors in a large rural area from India. A 10-year reflection.?Med Pharm Rep.?2019 Oct;?92(4): 408–412.

Alampally H, Chandrashekar C, Rodrigues G, Carnelio S.?Fascin in tooth germs: an immunohistochemical analysis.?Journal of Histotechnology. 2018; 41(1): 24-28.

Chandrashekar C, Sen S, Narayanaswamy V, Radhakrishnan R. A curious case of central odontogenic fibroma: A novel perspective. J Oral Maxillofac Pathol. 2018; 22(Suppl 1):S16-S19.

Patel PN,?Sah P,?Chandrashekar C,?Vidyasagar S,?Venkata Rao J,?Tiwari M,?Radhakrishnan R. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2017;125:10-19.

Kulkarni S, Chandrashekar C, Kudva R, Radhakrishnan R. Giant-cell fibroma: Understanding the nature of the melanin-laden cells. J Oral Maxillofac Pathol. 2017; 21(3):429-433.

Mutalik VS, Aparna M, Chandrashekar C,? Radhakrishnan R.??Margin control in oral squamous cell carcinoma: A survey of contemporary practice in India.?Journal of Oral and Maxillofacial Surgery Medicine Pathology. 2017; 29(5): 467-471.

Thennavan A,?Sharma M,?Chandrashekar C,?Hunter K,?Radhakrishnan R. Exploring the potential of laser capture microdissection technology in integrated oral biosciences. Oral Dis.?2017; 23(6):737-748.

Chandrasekar C, Salati N, Rao L, Radhakrishnan R. Salivary duct?carcinoma?in the?mandibular?anterior?region: The role of immunohistochemical markers in its definitive diagnosis. J Oral Maxillofac Pathol. 2016; 20(3):505-509.

Chetana Bhat, Kaveri Hallikeri, Punnya Angadi.?Aggressive osteoblastoma of the maxilla-a diagnostic conundrum.?Eastern J Med.?2016; 21(3):?145-149.

Solomon MC, Vidyasagar MS, Fernandes D, Guddattu V, Mathew M, Shergill AK, Carnelio S, Chandrashekar C. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study. Med Oncol. 2016; 33(12):138.

Patel PN, Thennavan A, Sen S, Chandrashekar C, Radhakrishnan R. Translational approach utilizing COX-2, p53, and MDM2 expressions in malignant transformation of oral submucous fibrosis. J Oral Sci. 2015; 57(3):169-76.

Natarajan J, Chandrashekar C, Radhakrishnan R. Critical biomarkers of epithelial mesenchymal transition in the head and neck cancers. J Cancer Res Ther. 2014; 10(3):512-8.

Sah P,?Menon A,?Kamath A,?Chandrashekar C,?Carnelio S,?Radhakrishnan R. Role of immunomarkers in the clinicopathological analysis of unicystic ameloblastoma. Dis Markers. 2013; 35(5):481-88.

Maheshwari P,?Chandrashekhar C,?Radhakrishnan R. Vascularized mandibular anterior ameloblastoma- An entity still unresolved. Minerva Stomatol. 2013; 62(5):183-88

Chandrashekar C, Angadi PV, Krishnapillai R. β-catenin expression in benign & malignant salivary gland tumors.? Int J Surg Pathol. 2011; 19(4): 433-40.

Laxmidevi LB,?Angadi PV,?Pillai RK,?Chandreshekar C. Aberrant β-catenin expression in the histologic differentiation of oral squamous cell carcinoma and verrucous carcinoma: An immunohistochemical study. J Oral Sci. 2010; 52(4): 633-40.